The Generation of Six Clinical-Grade Human Embryonic Stem Cell Lines

Cell Stem Cell

Volumn 1, Issue 5, 2007, Pages 490-494

  Crook, Jeremy Micah ^a   Peura, Teija Tuulikki ^b   Kravets, Lucy ^a   Bosman, Alexis Gina ^b   Buzzard, Jeremy James ^a   Horne, Rachel ^a   Hentze, Hannes ^a   Dunn, Norris Ray ^a   Zweigerdt, Robert ^a   Chua, Florence ^a   Upshall, Alan ^a   Colman, Alan ^a  

^a ES Cell International   (Singapore)

^b Sydney IVF   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; BOVINE SERUM ALBUMIN; DNA; MYOSIN HEAVY CHAIN ALPHA; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 2A; NESTIN; SOMATOMEDIN B; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

BLASTOCYST; CELL DIFFERENTIATION; CULTURE MEDIUM; DIPLOIDY; DNA FINGERPRINTING; DONOR SELECTION; EMBRYONIC STEM CELL; FIBROBLAST CULTURE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GOOD MANUFACTURING PRACTICE; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; INNER CELL MASS; KARYOTYPE; LETTER; MEDICAL ETHICS; MOSAICISM; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; TISSUE REPAIR; TRISOMY 16; ZONA PELLUCIDA;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; EMBRYO CULTURE TECHNIQUES; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; KARYOTYPING; MICE; MICE, SCID; STEM CELL TRANSPLANTATION; TERATOMA;

EID: 35848930381     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2007.10.004     Document Type: Letter

References (23)

1. Ashizawa S., Brunicardi F.C., and Wang X.P. Pancreas 28 (2004) 109-120
2. Benn P. Am. J. Med. Genet. 79 (1998) 121-133
3. Buzzard J.J., Gough N.M., Crook J.M., and Colman A. Nat. Biotechnol. 22 (2004) 381-382
4. Cowan C.A., Klimanskaya I., McMahon J., Atienza J., Witmyer J., Zucker J.P., Wang S., Morton C.C., McMahon A.P., Powers D., and Melton D.A. N. Engl. J. Med. 350 (2004) 1353-1356
5. Dai W., Field L.J., Rubart M., Reuter S., Hale S.L., Zweigerdt R., Graichen R.E., Kay G.L., Jyrala A., Colman A., et al. J. Mol. Cell. Cardiol. 43 (2007) 504-516
6. D'Alessandro J.S., Lu K., Fung B.P., Colman A., and Clarke D.L. Stem Cells Dev. 16 (2007) 75-89
7. Ellerstrom C., Strehl R., Moya K., Andersson K., Bergh C., Lundin K., Hyllner J., and Semb H. Stem Cells 24 (2006) 2170-2176
8. Fink D.W. Human embryonic stem cells: regulatory considerations. In: Lanza R.P. (Ed). Handbook of stem cells (2004), Elsevier Academic, Boston 775-786
9. U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research (1998). Guidance for Human Somatic Therapy and Gene Therapy.
10. Graichen R.E., Xu X.Q., Braam S.R., Balakrishnan T., Norfiza S., Sieh S., Soo S.Y., Tham S.C., Mummery C.L., Colman A., et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation (2007) in press
11. Heiskanen A., Satomaa T., Tiitinen S., Laitinen A., Mannelin S., Impola U., Mikkola M., Olsson C., Miller-Podraza H., Blomqvist M., et al. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25 (2007) 197-202
12. International Society of Stem Cell Research (2006). Guidelines for the conduct of human embryonic stem cell research. Version 1.
13. Klimanskaya I., Chung Y., Meisner L., Johnson J., West M.D., and Lanza R. Lancet 365 (2005) 1636-1641
14. Martin M.J., Muotri A., Gage F., and Varki A. Nat. Med. 11 (2005) 228-232
15. Mitalipova M.M., Calhoun J., Shin S., Wininger D., Schulz T., Noggle S., Venable A., Lyons I., Robins A., and Stice S. Stem Cells 21 (2003) 521-526
16. Mitalipova M.M., Rao R.R., Hoyer D.M., Johnson J.A., Meisner L.F., Jones K.L., Dalton S., and Stice S.L. Nat. Biotechnol. 23 (2005) 19-20
17. Peura T.T., Bosman A., and Stojanov T. Theriogenology 67 (2007) 32-42
18. Phillips B.W., Hentze H., Rust W.L., Chen Q.P., Chipperfield H., Tan E.K., Abraham S., Sadasivam A., Soong P.L., Wang S.T., et al. Stem Cells Dev. 16 (2007) 561-578
19. Rajala K., Hakala H., Panula S., Aivio S., Pihlajamäki H., Suuronen R., Hovatta O., and Skottman H. Hum. Reprod. 22 (2007) 1231-1238
20. Stephenson E.L., Braude P.R., and Mason C. Regen. Med. 1 (2006) 739-750
21. Committee on Guidelines for Human Embryonic Stem Cell Research National Research Council. Guidelines for Human Embryonic Stem Cell Research (2005), The National Academies Press, Washington, D.C.
22. Code of Federal Regulations (2006a). Food and Drugs, title 21, part 1270.
23. Code of Federal Regulations (2006b). Food and Drugs, title 21, part 1271.